SEC Form 4 · accession 0000899243-19-005477
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory T. Mayes
Director
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.61 | Feb 27, 2019 | A | 100,000 | A | — | Feb 26, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from March 1, 2019 through February 1, 2022, subject to the Reporting Person's continued service to the Company.